MVA/HIV62 vaccine

BIOLOGICAL2 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV Infections

Phase 2

Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults

CompletedNCT00820846

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2009-01-31End: 2014-09-30Updated: 2022-08-09

Unknown Phase

Early Immune Responses to Vaccination - A Substudy to HVTN 205

CompletedNCT00908323

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2009-07-31End: 2012-07-31Updated: 2021-10-15

Related Papers

Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.

2017-01-2510 citations